Search

Author/Creator Weickhardt, Andrew J.

3. Drug‐induced reduction in estimated glomerular filtration rate in patients with ALK‐positive non‐small cell lung cancer treated with the ALK inhibitor crizotinib. Issue 5 (20th November 2013)

Authors:
Brosnan, Evelyn M.; Weickhardt, Andrew J.; Lu, Xian; Maxon, Delee A.; Barón, Anna E.; Chonchol, Michel; Camidge, D. Ross
Journal:
Cancer
Issue:
Volume 120:Issue 5(2014)
Page Start:
664
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Drug‐induced reduction in estimated glomerular filtration rate in patients with ALK‐positive non‐small cell lung cancer treated with the ALK inhibitor crizotinib. Issue 5 (20th November 2013)

Authors:
Brosnan, Evelyn M.; Weickhardt, Andrew J.; Lu, Xian; Maxon, Delee A.; Barón, Anna E.; Chonchol, Michel; Camidge, D. Ross
Journal:
Cancer
Issue:
Volume 120:Issue 5(2014)
Page Start:
664
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. Issue 9 (14th June 2017)

Authors:
Yeung, Yvonne; Lau, David K.; Chionh, Fiona; Tran, Hoanh; Tse, Janson W. T.; Weickhardt, Andrew J.; Nikfarjam, Mehrdad; Scott, Andrew M.; Tebbutt, Niall C.; Mariadason, John M.
Journal:
Molecular oncology
Issue:
Volume 11:Issue 9(2017)
Page Start:
1130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose‐reduced 3‐weekly docetaxel for metastatic castration‐resistant prostate cancer. Issue 5 (10th January 2018)

Authors:
Hamid, Anis A.; Willson, Kaspar; Vincent, Andrew D.; Tamjid, Babak; Lee, Margaret; Bergin, Alice; Gan, Chun; Campbell, Ainsley; Stewart, Josephine; Pezaro, Carmel; Tran, Ben; Weickhardt, Andrew J.
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 14:Issue 5(2018)
Page Start:
e399
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Issue 13 (12th April 2013)

Authors:
Weickhardt, Andrew J.; Doebele, Robert C.; Purcell, W. Thomas; Bunn, Paul A.; Oton, Ana B.; Rothman, Micol S.; Wierman, Margaret E.; Mok, Tony; Popat, Sanjay; Bauman, Julie; Nieva, Jorge; Novello, Silvia; Ou, Sai‐Hong Ignatius; Camidge, D. Ross
Journal:
Cancer
Issue:
Volume 119:Issue 13(2013)
Page Start:
2383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Issue 13 (12th April 2013)

Authors:
Weickhardt, Andrew J.; Doebele, Robert C.; Purcell, W. Thomas; Bunn, Paul A.; Oton, Ana B.; Rothman, Micol S.; Wierman, Margaret E.; Mok, Tony; Popat, Sanjay; Bauman, Julie; Nieva, Jorge; Novello, Silvia; Ou, Sai‐Hong Ignatius; Camidge, D. Ross
Journal:
Cancer
Issue:
Volume 119:Issue 13(2013)
Page Start:
2383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗